According to Biolase 's latest financial reports the company's current earnings (TTM) are -$18.24 M. an increase over its 2022 earnings that were of -$25.78 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$18.24 M | -29.24% |
2022 | -$25.78 M | 85.86% |
2021 | -$13.87 M | -3.32% |
2020 | -$14.35 M | -8.21% |
2019 | -$15.63 M | -25.56% |
2018 | -$21 M | 19.75% |
2017 | -$17.54 M | 17.18% |
2016 | -$14.97 M | -27.53% |
2015 | -$20.65 M | 12.48% |
2014 | -$18.36 M | 66.18% |
2013 | -$11.05 M | 308.2% |
2012 | -$2.71 M | -37.32% |
2011 | -$4.32 M | -62.79% |
2010 | -$11.61 M | 317.49% |
2009 | -$2.78 M | -70.63% |
2008 | -$9.47 M | 5.48% |
2007 | -$8.97 M | 85.41% |
2006 | -$4.84 M | -71.51% |
2005 | -$16.98 M | 87.79% |
2004 | -$9.05 M | |
2001 | -$0.37 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | $0.65 B | -3,700.27% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | -$94 M | 415.38% | ๐บ๐ธ USA |